Stay updated on Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed from the page history.
    Difference
    0.0%
    Check dated 2026-03-12T00:26:14.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    A new Revision: v3.4.2 tag appears on the page, indicating a version update; there is no visible change to study details or instructions.
    Difference
    0.3%
    Check dated 2026-02-11T14:22:18.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding status and NIH Clinical Center operations, and updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T10:27:03.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a new 'Show glossary' option. Updated metadata labels (e.g., 'Last Update Submitted that Met QC Criteria', capitalization of 'No FEAR Act Data') and introduced a 'Revision: v3.4.0' tag.
    Difference
    0.1%
    Check dated 2026-01-28T06:24:09.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 and removed Revision: v3.3.3, reflecting a routine version update with no changes to study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:18:42.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added Revision: v3.3.3; removed HHS Vulnerability Disclosure and Revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-12-23T21:17:06.000Z thumbnail image

Stay in the know with updates to Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial page.